Woman reading in MDC library

Veröffentlichungen

14 Ergebnisse:
Active Filter:
Sortieren:
in BMC Med Genomics

Identification and ranking of recurrent neo-epitopes in cancer

  • E. Blanc
  • M. Holtgrewe
  • A. Dhamodaran
  • C. Messerschmidt
  • G. Willimsky
  • T. Blankenstein
  • D. Beule
in BMC Bioinformatics

SigsPack, a package for cancer mutational signatures

  • F. Schumann
  • E. Blanc
  • C. Messerschmidt
  • T. Blankenstein
  • A. Busse
  • D. Beule
in Leukemia

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies

  • N. Çakmak-Görür
  • J. Radke
  • S. Rhein
  • E. Schumann
  • G. Willimsky
  • F.L. Heppner
  • T. Blankenstein
  • A. Pezzutto
in OncoImmunology

Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer

  • L. Penter
  • K. Dietze
  • J. Ritter
  • M.F. Lammoglia Cobo
  • J. Garmshausen
  • F. Aigner
  • L. Bullinger
  • H. Hackstein
  • S. Wienzek-Lischka
  • T. Blankenstein
  • M. Hummel
  • K. Dornmair
  • L. Hansmann
in Front Immunol

Interferon-γ receptor signaling in dendritic cells restrains spontaneous proliferation of CD4(+) T cells in chronic lymphopenic mice

  • L. Knop
  • C. Frommer
  • D. Stoycheva
  • K. Deiser
  • U. Kalinke
  • T. Blankenstein
  • T. Kammertoens
  • I.R. Dunay
  • T. Schüler
in J Clin Invest

Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression

  • L. Poncette
  • X. Chen
  • F.K.M. Lorenz
  • T. Blankenstein
in Int J Cancer

Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB

  • A. Flörcken
  • M. Grau
  • A. Wolf
  • A. Weilemann
  • J. Kopp
  • B. Dörken
  • T. Blankenstein
  • A. Pezzutto
  • P. Lenz
  • G. Lenz
  • J. Westermann
in Curr Opin Immunol

Targeting cancer-specific mutations by T cell receptor gene therapy

  • T. Blankenstein
  • M. Leisegang
  • W. Uckert
  • H. Schreiber
in Nat Biotechnol

Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice

  • M. Obenaus
  • C. Leitão
  • M. Leisegang
  • X. Chen
  • I. Gavvovidis
  • P. van der Bruggen
  • W. Uckert
  • D.J. Schendel
  • T. Blankenstein
in Canc Cell

Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer

  • K. Anders
  • C. Buschow
  • A. Herrmann
  • A. Milojkovic
  • C. Loddenkemper
  • T. Kammertoens
  • P. Daniel
  • H. Yu
  • J. Charo
  • T. Blankenstein